Tesamorelin Online: Egrifta vs Compounded, and What It Costs
Tesamorelin is the only growth-hormone-releasing hormone (GHRH) analog with a current FDA approval, and that approval is narrow: reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Here is what it costs online, what the trials showed, and how it differs from sermorelin. The FDA label doses are on our tesamorelin profile, linked below.
Last checked Prices checked 11 sources · 5 questions No paid links on this page Education, not medical advice
The short answer
From 11 sources- Compounded, online: we list no compounded tesamorelin seller. FDA has regulated tesamorelin as a biological product since March 23, 2020, and biologics are not eligible for the 503A and 503B compounding exemptions.
- Brand-name Egrifta WR: about $11,030 a month (one 28-day kit) at a cash price (Drugs.com listing, Oct 29, 2026). Insurance usually covers it only for the approved HIV indication.
- Tesamorelin vs sermorelin: tesamorelin has an FDA approval and phase 3 visceral-fat trials; sermorelin has no approved product today but costs less online, from $99/mo.
Tesamorelin prices
Sorted by the lowest published monthly cost. Affiliate status never changes the order.
Every price we found
1 offer · checked Oct 29, 2026| Seller | Product | Price | Status | Includes |
|---|---|---|---|---|
| Egrifta WR (Theratechnologies) | Brand tesamorelin, 1 kit = 4 vials, a 28-day supply | About $11,030 per kit, cash (Drugs.com listing)seller's list price | FDA-approved brand | Medication only. Approved only for HIV-associated lipodystrophy; insurance or the maker’s THERA co-pay program may lower the cost for that use |
What the trials showed, and for whom
Two 26-week, placebo-controlled phase 3 trials enrolled 816 adults with HIV on stable antiretroviral therapy and excess abdominal fat. Daily 2 mg tesamorelin cut visceral fat (measured by CT) by 18% and 14% in the two studies, against +2% and −2% on placebo (Egrifta WR label). In the first trial, published in NEJM, triglycerides and the cholesterol-to-HDL ratio also improved.
In a pooled analysis, fat under the skin of the abdomen did not change significantly over the first 26 weeks, and in patients who kept taking tesamorelin the visceral-fat reduction held through 52 weeks. Body weight barely moved: the label calls the effect weight-neutral.
These trials studied one population: adults with HIV-associated lipodystrophy. They do not show what tesamorelin does for people without that condition, and we make no claims about other uses.
Tesamorelin vs sermorelin: the differences that matter
Both are GHRH analogs that prompt the pituitary to release growth hormone. Neither is better for everyone; the differences are approval, evidence, cost and monitoring.
| Tesamorelin | Sermorelin | |
|---|---|---|
| FDA status | Approved as Egrifta for excess abdominal fat in adults with HIV-associated lipodystrophy only | No approved product. Geref was discontinued in 2008; FDA found it was not withdrawn for safety or effectiveness |
| What telehealth sells | Compounded (no FDA compounding pathway for a biologic) or brand Egrifta by prescription | Compounded only |
| Molecule | 44-amino-acid GHRH analog | The first 29 amino acids of GHRH |
| Visceral-fat evidence | Two 26-week phase 3 trials in HIV lipodystrophy (816 patients) | Its former approval (Geref) was for children with growth hormone deficiency; never approved for visceral fat |
| Online cost | Egrifta WR about $11,030/mo cash (one 28-day kit); we list no compounded seller | From $99/mo after a $49 first month (Embody); see our sermorelin page |
| Monitoring | Label: check IGF-1 during treatment and glucose before and during; consider stopping if IGF-1 stays high | No current US label; monitoring varies by clinic |
| Contraindications | Label: disrupted hypothalamic-pituitary axis, active cancer, hypersensitivity, pregnancy | No current US label; ask the prescriber |
| Tested athletes | Prohibited (WADA S2.2.4) | Prohibited (WADA S2.2.4) |
Safety points from the FDA label
- Raises IGF-1, a growth factor; the effect of long-term high IGF-1 is unknown, so the label says to monitor it.
- Can cause glucose intolerance or diabetes: in the trials, 5% on tesamorelin vs 1% on placebo developed an HbA1c of 6.5% or higher.
- Fluid retention (swelling, joint pain, carpal tunnel), injection-site reactions and hypersensitivity reactions.
- Not for use with active cancer, a disrupted hypothalamic-pituitary axis (for example after pituitary surgery or radiation), or in pregnancy.
Who shouldn’t buy it online
Tested athletes (WADA prohibits it at all times), anyone with active cancer, a disrupted hypothalamic-pituitary axis or a pregnancy, anyone told to avoid growth-hormone-related treatment, and anyone offered “research use only” vials instead of a prescription.
Questions
Common questions
5 answersIs tesamorelin FDA-approved?
Yes, but only as Egrifta (Egrifta SV and Egrifta WR) for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. The label says it is not for weight-loss management. Other uses are off-label, and compounded tesamorelin is not FDA-approved.
How much does tesamorelin cost online?
On Oct 29, 2026, brand-name Egrifta WR listed at about $11,030 a month (one 28-day kit) at a cash price on Drugs.com; insurance may cover it for the approved HIV indication. We list no compounded tesamorelin seller: FDA has regulated tesamorelin as a biological product since March 23, 2020, and biologics are not eligible for the 503A and 503B compounding exemptions.
Is tesamorelin better than sermorelin?
Not across the board. Tesamorelin has an FDA approval and phase 3 trials showing visceral-fat reduction in adults with HIV-associated lipodystrophy. Sermorelin has no approved product today but costs less online. Which fits depends on your health, goals and budget; a clinician should decide.
Do I need labs for tesamorelin?
The Egrifta label says to monitor IGF-1 during treatment and to check glucose before and during therapy. Ask any online provider what labs they order and how often.
Can athletes use tesamorelin?
No for tested athletes: WADA lists tesamorelin by name under growth hormone releasing factors (S2.2.4), prohibited in and out of competition.
Regulatory status
Tesamorelin is FDA-approved only under the Egrifta name (Egrifta, Egrifta SV and Egrifta WR), for reducing excess abdominal fat in adults with HIV and lipodystrophy. The label says it is not indicated for weight-loss management, and long-term cardiovascular safety has not been established. Any other use is off-label.
Since March 23, 2020, FDA has regulated tesamorelin as a biological product, and FDA says biologics are not eligible for the compounding exemptions in sections 503A and 503B. Compounded tesamorelin is not FDA-approved; ask any provider which product and which pharmacy would fill your prescription.
Not medical advice. Outside HIV-associated lipodystrophy, tesamorelin has no FDA-reviewed indication. A licensed clinician decides whether it is appropriate for you; individual results vary.
Sources
Sources cited on this page
11 sources · read Oct 29, 2026Prices and product facts come from each seller’s own pages, read Oct 29, 2026. We link only to sellers we have an affiliate relationship with and to government and research sources; other sellers' prices are quoted as plain text.
- 1FDA: Egrifta WR prescribing information (March 2025) (opens in new tab)accessdata.fda.gov
- 2FDA Purple Book: Egrifta, Egrifta SV, Egrifta WR (BLA 022505) (opens in new tab)purplebooksearch.fda.gov
- 3FDA: Notice to compounders, changes as of March 23, 2020 (opens in new tab)fda.gov
- 4FDA: NDAs for biological products deemed BLAs on March 23, 2020 (includes Egrifta) (opens in new tab)fda.gov
- 5FDA: Compounding questions and answers (can biologics be compounded?) (opens in new tab)fda.gov
- 6Falutz et al., NEJM 2007: tesamorelin in HIV patients with abdominal fat (opens in new tab)pubmed.ncbi.nlm.nih.gov
- 7Falutz et al., JCEM 2010: pooled phase 3 analysis with 52-week data (opens in new tab)pubmed.ncbi.nlm.nih.gov
- 8Federal Register (2013): Geref (sermorelin) not withdrawn for safety or effectiveness (opens in new tab)federalregister.gov
- 9WADA: Prohibited List (S2.2.4) (opens in new tab)wada-ama.org
- 10Embody: sermorelin $49 first month, then $99/mo (opens in new tab)sermorelin.joinem.co
Keep reading: Online telehealth compared
Online telehealth compared: every pageTelehealth comparisonsBrowse all topics
- Previous in this topicNAD+ Injection Costs: Providers and Billing ComparedPrescription NAD+ from telehealth clinics costs $69 to $249 a month, and no NAD+ injection is FDA-approved.
- Next in this topicGlutathione Injections: Providers, Prices & Evidence (2026)Compare Embody, AgelessRx, Nuform and System Labs glutathione offers: product forms, upfront and ongoing costs, plus oral alternatives and human evidence.
- PT-141 (Bremelanotide) Online Cost (2026): Vyleesi $0–$99 and Compounded BremelanotideWhat PT-141 costs: FDA-approved Vyleesi is $0 for most commercially insured patients or $99 per 4-dose box without coverage.
- Trying to Conceive Tools Cost (2026): Ovulation Strips From $9.99, Natural Cycles, Oova, PrenatalsWhat trying-to-conceive tools cost: Easy@Home LH strips $9.99–$27.99, an Rx prenatal $7.14 for 30 at Cost Plus Drugs, Natural Cycles about $12.50/mo (annual plan), FullWell…
- B12 Injections Online: Costs and Plans from $65/moCompare plain B12 and B12/MIC plans: AgelessRx advertises B12 from $65/mo on a 3-month plan and B12/MIC from $110/mo, checked Nov 6, 2026.